Compile Data Set for Download or QSAR
Report error Found 104 Enz. Inhib. hit(s) with all data for entry = 50019355
TargetC-C chemokine receptor type 8(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50203831(N-(4-{[(1-butyrylpiperidin-4-yl)amino]sulfonyl}-1-...)
Affinity DataIC50: 0.300nMAssay Description:Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 8(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50203869(3-pyrrolidin-1-ylpropyl 4-[({4-[(2-methylbenzoyl)a...)
Affinity DataIC50: 4.20nMAssay Description:Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 8(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50203908(N-(4-{[(1-butyrylpiperidin-4-yl)amino]sulfonyl}-1-...)
Affinity DataIC50: 5.10nMAssay Description:Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 8(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50203922(cyclohexanecarboxylic acid [4-(1-butyryl-piperidin...)
Affinity DataIC50: 6.10nMAssay Description:Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 8(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50203899(4-tert-butyl-N-(4-{[(1-butyrylpiperidin-4-yl)amino...)
Affinity DataIC50: 6.90nMAssay Description:Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 8(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50203877(N-(4-{[(1-butyrylpiperidin-4-yl)amino]sulfonyl}-1-...)
Affinity DataIC50: 7.65nMAssay Description:Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 8(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50203842(N-(4-{[(1-butyrylpiperidin-4-yl)amino]sulfonyl}-1-...)
Affinity DataIC50: 9.5nMAssay Description:Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 8(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50203870(3-(dimethylamino)propyl 4-[({4-[(2-methylbenzoyl)a...)
Affinity DataIC50: 9.80nMAssay Description:Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 8(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50203896(N-(4-{[(1-butyrylpiperidin-4-yl)amino]sulfonyl}-1-...)
Affinity DataIC50: 10.8nMAssay Description:Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 8(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50203864(N-(4-{[(1-butyrylpiperidin-4-yl)amino]-sulfonyl}-1...)
Affinity DataIC50: 12.5nMAssay Description:Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 8(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50203887(3-(diethylamino)propyl 4-[({4-[(2-methylbenzoyl)am...)
Affinity DataIC50: 14.5nMAssay Description:Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 8(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50203915(4-butyl-N-(4-{[(1-butyrylpiperidin-4-yl)amino]sulf...)
Affinity DataIC50: 15.3nMAssay Description:Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 8(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50203907(N-[4-(1-butyryl-piperidin-4-ylsulfamoyl)-naphthale...)
Affinity DataIC50: 19.2nMAssay Description:Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 8(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50203893(3-(2,6-dimethylmorpholin-4-yl)propyl-4-[({4-[(2-me...)
Affinity DataIC50: 19.6nMAssay Description:Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 8(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50203852(N-(4-{[(1-butyrylpiperidin-4-yl)amino]sulfonyl}-1-...)
Affinity DataIC50: 20nMAssay Description:Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 8(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50203891(N-(4-{[(1-butyrylpiperidin-4-yl)amino]sulfonyl}-1-...)
Affinity DataIC50: 20.4nMAssay Description:Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 8(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50203894(N-(4-{[(1-butyrylpiperidin-4-yl)amino]sulfonyl}-1-...)
Affinity DataIC50: 23.6nMAssay Description:Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 8(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50203906(4-(benzyloxy)-N-(4-{[(1-butyrylpiperidin-4-yl)amin...)
Affinity DataIC50: 24.6nMAssay Description:Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 8(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50203886(3-(3,4-dihydroisoquinolin-2(1H)-yl)propyl 4-[({4-[...)
Affinity DataIC50: 28.6nMAssay Description:Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 8(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50203830(N-(4-{[(1-butyrylpiperidin-4-yl)amino]sulfonyl}-1-...)
Affinity DataIC50: 36.1nMAssay Description:Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 8(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50203927(3-tert-butyl-N-(4-{[(1-butyrylpiperidin-4-yl)amino...)
Affinity DataIC50: 37nMAssay Description:Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 8(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50203912(N-(4-{[(1-butyrylpiperidin-4-yl)amino]sulfonyl}-1-...)
Affinity DataIC50: 41.7nMAssay Description:Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 8(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50203858(N-(4-{[(1-butyrylpiperidin-4-yl)amino]sulfonyl}-1-...)
Affinity DataIC50: 43.9nMAssay Description:Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 8(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50203913(N-(4-{[(1-butyrylpiperidin-4-yl)amino]sulfonyl}-1-...)
Affinity DataIC50: 46.9nMAssay Description:Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 8(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50203845(cyclobutanecarboxylic acid [4-(1-butyryl-piperidin...)
Affinity DataIC50: 57.9nMAssay Description:Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 8(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50203903(N-(4-{[(1-butyrylpiperidin-4-yl)amino]sulfonyl}-1-...)
Affinity DataIC50: 59.5nMAssay Description:Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 8(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50203885(ethyl 4-({[4-(Isonicotinoylamino)-1-naphthyl]sulfo...)
Affinity DataIC50: 100nMAssay Description:Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 8(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50203923(N-(4-{[(1-butyrylpiperidin-4-yl)amino]sulfonyl}-1-...)
Affinity DataIC50: 145nMAssay Description:Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 8(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50203868(N-[4-(4-methoxy-phenylsulfamoyl)-naphthalen-1-yl]-...)
Affinity DataIC50: 150nMAssay Description:Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 8(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50203833(tetrahydro-pyran-4-carboxylic acid [4-(1-butyryl-p...)
Affinity DataIC50: 206nMAssay Description:Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 8(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50203851(N-[4-(1-butyryl-piperidin-4-ylsulfamoyl)-naphthale...)
Affinity DataIC50: 280nMAssay Description:Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 8(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50203884(cyclopentanecarboxylic acid [4-(1-butyryl-piperidi...)
Affinity DataIC50: 365nMAssay Description:Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 8(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50203904(cyclopropanecarboxylic acid [4-(1-butyryl-piperidi...)
Affinity DataIC50: 368nMAssay Description:Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 8(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50203863(N-(4-{[(1-butyrylpiperidin-4-yl)amino]sulfonyl}-1-...)
Affinity DataIC50: 613nMAssay Description:Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 8(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50203844(N-(4-{[(1-butyrylpiperidin-4-yl)amino]sulfonyl}-1-...)
Affinity DataIC50: 639nMAssay Description:Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 8(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50203861(N-(4-{[(1-butyrylpiperidin-4-yl)amino]sulfonyl}-1-...)
Affinity DataIC50: 885nMAssay Description:Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 8(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50203854(N-(4-{[(1-butyrylpiperidin-4-yl)amino]sulfonyl}-1-...)
Affinity DataIC50: 1.00E+3nMAssay Description:Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 8(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50203839(N-(4-{[(1-butyrylpiperidin-4-yl)amino]sulfonyl}-1-...)
Affinity DataIC50: 1.52E+3nMAssay Description:Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 8(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50203838(1-methyl-piperidine-4-carboxylic acid [4-(1-butyry...)
Affinity DataIC50: 1.90E+3nMAssay Description:Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 8(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50203883(N-(1-butyrylpiperidin-4-yl)-4-[(2-methylbenzoyl)am...)
Affinity DataIC50: 3.30E+3nMAssay Description:Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 8(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50203902(N-(4-{[(1-butyrylpiperidin-4-yl)amino]methyl}-1-na...)
Affinity DataIC50: 3.30E+3nMAssay Description:Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCytochrome P450 3A4(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50203881(4-[4-(2-methyl-benzoylamino)-naphthalene-1-sulfony...)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of CYP3A4More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 8(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50203905(4-(4-benzoylamino-naphthalene-1-sulfonylamino)-pip...)
Affinity DataKi:  0.170nMAssay Description:Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 8(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50203831(N-(4-{[(1-butyrylpiperidin-4-yl)amino]sulfonyl}-1-...)
Affinity DataKi:  0.300nMAssay Description:Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 8(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50203832(4-[4-(2-methyl-benzoylamino)-naphthalene-1-sulfony...)
Affinity DataKi:  0.700nMAssay Description:Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 8(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50203834(2-methyl-N-{4-[({1-[(2S)-pyrrolidin-2-ylcarbonyl]p...)
Affinity DataKi:  0.700nMAssay Description:Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 8(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50203834(2-methyl-N-{4-[({1-[(2S)-pyrrolidin-2-ylcarbonyl]p...)
Affinity DataKi:  0.700nMAssay Description:Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 8(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50203919(2-methyl-N-[4-({[1-(pyrrolidin-1-ylcarbonyl)piperi...)
Affinity DataKi:  1.10nMAssay Description:Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 8(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50203914(N-[4-({[1-(azetidin-3-ylcarbonyl)piperidin-4-yl]am...)
Affinity DataKi:  1.5nMAssay Description:Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 8(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50203871(4-({[4-(benzoylamino)-1-naphthyl]sulfonyl}amino)-N...)
Affinity DataKi:  1.60nMAssay Description:Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
Displayed 1 to 50 (of 104 total ) | Next | Last >>
Jump to: